Growth Metrics

Quest Diagnostics (DGX) Non-Current Debt (2016 - 2026)

Quest Diagnostics' Non-Current Debt history spans 18 years, with the latest figure at $5.2 billion for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 12.0% to $5.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.2 billion, a 12.0% decrease, with the full-year FY2025 number at $5.2 billion, down 7.98% from a year prior.
  • Non-Current Debt hit $5.2 billion in Q1 2026 for Quest Diagnostics, roughly flat from $5.2 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for DGX hit a ceiling of $5.9 billion in Q1 2025 and a floor of $3.8 billion in Q2 2023.
  • Historically, Non-Current Debt has averaged $4.6 billion across 5 years, with a median of $4.0 billion in 2022.
  • Biggest five-year swings in Non-Current Debt: surged 54.0% in 2025 and later dropped 12.0% in 2026.
  • Tracing DGX's Non-Current Debt over 5 years: stood at $4.0 billion in 2022, then grew by 10.86% to $4.4 billion in 2023, then increased by 27.32% to $5.6 billion in 2024, then dropped by 7.98% to $5.2 billion in 2025, then decreased by 0.23% to $5.2 billion in 2026.
  • Business Quant data shows Non-Current Debt for DGX at $5.2 billion in Q1 2026, $5.2 billion in Q4 2025, and $5.2 billion in Q3 2025.